世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のデジタル慢性疾患管理市場の成長(現状と展望)2023-2029年


Global Digital Chronic Disease Management Market Growth (Status and Outlook) 2023-2029

LPI(LPインフォメーション)の最新調査によると、世界のデジタル慢性疾患管理市場規模は2022年に100万米ドルと評価されました。川下市場での需要拡大とCOVID-19やロシア・ウクライナ戦争の影響からの回復により... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2023年9月5日 US$3,660
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
121 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

LPI(LPインフォメーション)の最新調査によると、世界のデジタル慢性疾患管理市場規模は2022年に100万米ドルと評価されました。川下市場での需要拡大とCOVID-19やロシア・ウクライナ戦争の影響からの回復により、デジタル慢性疾患管理は2029年までに100万米ドルの再調整規模になると予測され、レビュー期間中のCAGRは%である。
この調査レポートは、世界のデジタル慢性疾患管理市場の成長可能性を明らかにしています。COVID-19やロシア・ウクライナ戦争の影響からの回復に伴い、デジタル慢性疾患管理は今後の市場で安定した成長を示すと予想される。しかし、製品の差別化、コスト削減、サプライチェーンの最適化は、デジタル慢性疾患管理を広く普及させるために引き続き重要である。市場参入企業は、デジタル慢性疾患管理市場が提供する膨大な機会を活用するために、研究開発への投資、戦略的パートナーシップの構築、進化する消費者の嗜好に合わせた製品提供を行う必要があります。
デジタル慢性疾患管理とは、慢性非伝染性疾患とその危険因子の定期的な検出、継続的なモニタリング、評価、包括的な介入管理を行うために、オンライン・ソフトウェアやインテリジェント・ハードウェアを使用する医療行為とプロセスを指す。疾病リスク予測、早期警告、包括的介入だけでなく、慢性疾患集団の包括的管理、慢性疾患の影響評価なども含まれる。
主な特徴
デジタル慢性疾患管理市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長:この調査レポートは、デジタル慢性疾患管理市場の現在の規模と成長の概要を提供します。過去のデータ、タイプ別(有料、無料など)の市場細分化、地域別内訳などが含まれます。
市場促進要因と課題:政府規制、環境問題、技術進歩、消費者嗜好の変化など、デジタル慢性疾患管理市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制約、射程距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができます。
競合情勢:この調査レポートは、デジタル慢性疾患管理市場における競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれています。また、新興プレーヤーとその潜在的な市場への影響も強調することができます。
技術開発:調査レポートは、デジタル慢性疾患管理業界における最新の技術開発を掘り下げることができます。これには、デジタル慢性疾患管理技術の進歩、デジタル慢性疾患管理の新規参入、デジタル慢性疾患管理の新規投資、デジタル慢性疾患管理の将来を形作るその他のイノベーションなどが含まれます。
川下の事業者の好み:本レポートは、デジタル慢性疾患管理市場における顧客の購買行動や採用動向を明らかにします。顧客の購買決定やデジタル慢性疾患管理製品の嗜好に影響を与える要因も含まれます。
政府の政策とインセンティブ調査レポートは、政府の政策やインセンティブがデジタル慢性疾患管理市場に与える影響を分析します。これには、デジタル慢性疾患管理市場の促進を目的とした規制枠組み、補助金、税制優遇措置などの評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境への影響と持続可能性調査レポートは、デジタル慢性疾患管理市場の環境影響と持続可能性の側面を評価します。
市場予測と将来展望:実施した分析に基づき、調査レポートはデジタル慢性疾患管理産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートでは最後に、業界関係者、政策立案者、投資家への提言を行っています。市場関係者が新たなトレンドを活用し、課題を克服し、デジタル慢性疾患管理市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場細分化:
デジタル慢性疾患管理市場は、タイプ別と用途別に分類されます。2018年から2029年までの期間について、セグメント間の成長により、タイプ別、およびアプリケーション別の消費額の正確な計算と予測を提供します。
タイプ別セグメント
チャージ
無料
用途別セグメント
医療機関
薬局
慢性疾患患者
本レポートでは、市場を地域別にも分割しています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
S3 コネクテッド・ヘルス
ウェルドック
アストラゼネカ
NTTデータ
クレドヘルスサービス
ドーンヘルス
バイエル
メドトロニック
テラドックヘルス
サイエンスソフト
トライゼット・ヘルスケア(コグニザント)
オマダヘルス
ファブル
パックヘルス
エピック・システムズ
パスメイト
エブリドーズ
Aptar デジタルヘルス
VITech
ClouDrグループ
JDヘルス
アリヘルス
平安グッドドクター
Weドクターグループ
ウェイ・マイ
メドリンカー


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Digital Chronic Disease Management Market Size 2018-2029
2.1.2 Digital Chronic Disease Management Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Digital Chronic Disease Management Segment by Type
2.2.1 Charge
2.2.2 Free
2.3 Digital Chronic Disease Management Market Size by Type
2.3.1 Digital Chronic Disease Management Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Digital Chronic Disease Management Market Size Market Share by Type (2018-2023)
2.4 Digital Chronic Disease Management Segment by Application
2.4.1 Medical Institutions
2.4.2 Pharmacy
2.4.3 Chronic Disease Patients
2.5 Digital Chronic Disease Management Market Size by Application
2.5.1 Digital Chronic Disease Management Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Digital Chronic Disease Management Market Size Market Share by Application (2018-2023)
3 Digital Chronic Disease Management Market Size by Player
3.1 Digital Chronic Disease Management Market Size Market Share by Players
3.1.1 Global Digital Chronic Disease Management Revenue by Players (2018-2023)
3.1.2 Global Digital Chronic Disease Management Revenue Market Share by Players (2018-2023)
3.2 Global Digital Chronic Disease Management Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Digital Chronic Disease Management by Regions
4.1 Digital Chronic Disease Management Market Size by Regions (2018-2023)
4.2 Americas Digital Chronic Disease Management Market Size Growth (2018-2023)
4.3 APAC Digital Chronic Disease Management Market Size Growth (2018-2023)
4.4 Europe Digital Chronic Disease Management Market Size Growth (2018-2023)
4.5 Middle East & Africa Digital Chronic Disease Management Market Size Growth (2018-2023)
5 Americas
5.1 Americas Digital Chronic Disease Management Market Size by Country (2018-2023)
5.2 Americas Digital Chronic Disease Management Market Size by Type (2018-2023)
5.3 Americas Digital Chronic Disease Management Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Digital Chronic Disease Management Market Size by Region (2018-2023)
6.2 APAC Digital Chronic Disease Management Market Size by Type (2018-2023)
6.3 APAC Digital Chronic Disease Management Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Digital Chronic Disease Management by Country (2018-2023)
7.2 Europe Digital Chronic Disease Management Market Size by Type (2018-2023)
7.3 Europe Digital Chronic Disease Management Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Digital Chronic Disease Management by Region (2018-2023)
8.2 Middle East & Africa Digital Chronic Disease Management Market Size by Type (2018-2023)
8.3 Middle East & Africa Digital Chronic Disease Management Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Digital Chronic Disease Management Market Forecast
10.1 Global Digital Chronic Disease Management Forecast by Regions (2024-2029)
10.1.1 Global Digital Chronic Disease Management Forecast by Regions (2024-2029)
10.1.2 Americas Digital Chronic Disease Management Forecast
10.1.3 APAC Digital Chronic Disease Management Forecast
10.1.4 Europe Digital Chronic Disease Management Forecast
10.1.5 Middle East & Africa Digital Chronic Disease Management Forecast
10.2 Americas Digital Chronic Disease Management Forecast by Country (2024-2029)
10.2.1 United States Digital Chronic Disease Management Market Forecast
10.2.2 Canada Digital Chronic Disease Management Market Forecast
10.2.3 Mexico Digital Chronic Disease Management Market Forecast
10.2.4 Brazil Digital Chronic Disease Management Market Forecast
10.3 APAC Digital Chronic Disease Management Forecast by Region (2024-2029)
10.3.1 China Digital Chronic Disease Management Market Forecast
10.3.2 Japan Digital Chronic Disease Management Market Forecast
10.3.3 Korea Digital Chronic Disease Management Market Forecast
10.3.4 Southeast Asia Digital Chronic Disease Management Market Forecast
10.3.5 India Digital Chronic Disease Management Market Forecast
10.3.6 Australia Digital Chronic Disease Management Market Forecast
10.4 Europe Digital Chronic Disease Management Forecast by Country (2024-2029)
10.4.1 Germany Digital Chronic Disease Management Market Forecast
10.4.2 France Digital Chronic Disease Management Market Forecast
10.4.3 UK Digital Chronic Disease Management Market Forecast
10.4.4 Italy Digital Chronic Disease Management Market Forecast
10.4.5 Russia Digital Chronic Disease Management Market Forecast
10.5 Middle East & Africa Digital Chronic Disease Management Forecast by Region (2024-2029)
10.5.1 Egypt Digital Chronic Disease Management Market Forecast
10.5.2 South Africa Digital Chronic Disease Management Market Forecast
10.5.3 Israel Digital Chronic Disease Management Market Forecast
10.5.4 Turkey Digital Chronic Disease Management Market Forecast
10.5.5 GCC Countries Digital Chronic Disease Management Market Forecast
10.6 Global Digital Chronic Disease Management Forecast by Type (2024-2029)
10.7 Global Digital Chronic Disease Management Forecast by Application (2024-2029)

11 Key Players Analysis
11.1 S3 Connected Health
11.1.1 S3 Connected Health Company Information
11.1.2 S3 Connected Health Digital Chronic Disease Management Product Offered
11.1.3 S3 Connected Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 S3 Connected Health Main Business Overview
11.1.5 S3 Connected Health Latest Developments
11.2 WellDoc
11.2.1 WellDoc Company Information
11.2.2 WellDoc Digital Chronic Disease Management Product Offered
11.2.3 WellDoc Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 WellDoc Main Business Overview
11.2.5 WellDoc Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Digital Chronic Disease Management Product Offered
11.3.3 AstraZeneca Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 NTT DATA
11.4.1 NTT DATA Company Information
11.4.2 NTT DATA Digital Chronic Disease Management Product Offered
11.4.3 NTT DATA Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 NTT DATA Main Business Overview
11.4.5 NTT DATA Latest Developments
11.5 Credo Health Services
11.5.1 Credo Health Services Company Information
11.5.2 Credo Health Services Digital Chronic Disease Management Product Offered
11.5.3 Credo Health Services Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Credo Health Services Main Business Overview
11.5.5 Credo Health Services Latest Developments
11.6 Dawn Health
11.6.1 Dawn Health Company Information
11.6.2 Dawn Health Digital Chronic Disease Management Product Offered
11.6.3 Dawn Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Dawn Health Main Business Overview
11.6.5 Dawn Health Latest Developments
11.7 Bayer
11.7.1 Bayer Company Information
11.7.2 Bayer Digital Chronic Disease Management Product Offered
11.7.3 Bayer Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Bayer Main Business Overview
11.7.5 Bayer Latest Developments
11.8 Medtronic
11.8.1 Medtronic Company Information
11.8.2 Medtronic Digital Chronic Disease Management Product Offered
11.8.3 Medtronic Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Medtronic Main Business Overview
11.8.5 Medtronic Latest Developments
11.9 Teladoc Health
11.9.1 Teladoc Health Company Information
11.9.2 Teladoc Health Digital Chronic Disease Management Product Offered
11.9.3 Teladoc Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Teladoc Health Main Business Overview
11.9.5 Teladoc Health Latest Developments
11.10 ScienceSoft
11.10.1 ScienceSoft Company Information
11.10.2 ScienceSoft Digital Chronic Disease Management Product Offered
11.10.3 ScienceSoft Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 ScienceSoft Main Business Overview
11.10.5 ScienceSoft Latest Developments
11.11 TriZetto Healthcare (Cognizant)
11.11.1 TriZetto Healthcare (Cognizant) Company Information
11.11.2 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Product Offered
11.11.3 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 TriZetto Healthcare (Cognizant) Main Business Overview
11.11.5 TriZetto Healthcare (Cognizant) Latest Developments
11.12 Omada Health
11.12.1 Omada Health Company Information
11.12.2 Omada Health Digital Chronic Disease Management Product Offered
11.12.3 Omada Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Omada Health Main Business Overview
11.12.5 Omada Health Latest Developments
11.13 Phable
11.13.1 Phable Company Information
11.13.2 Phable Digital Chronic Disease Management Product Offered
11.13.3 Phable Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Phable Main Business Overview
11.13.5 Phable Latest Developments
11.14 Pack Health
11.14.1 Pack Health Company Information
11.14.2 Pack Health Digital Chronic Disease Management Product Offered
11.14.3 Pack Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Pack Health Main Business Overview
11.14.5 Pack Health Latest Developments
11.15 Epic Systems
11.15.1 Epic Systems Company Information
11.15.2 Epic Systems Digital Chronic Disease Management Product Offered
11.15.3 Epic Systems Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Epic Systems Main Business Overview
11.15.5 Epic Systems Latest Developments
11.16 Pathmate
11.16.1 Pathmate Company Information
11.16.2 Pathmate Digital Chronic Disease Management Product Offered
11.16.3 Pathmate Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Pathmate Main Business Overview
11.16.5 Pathmate Latest Developments
11.17 EveryDose
11.17.1 EveryDose Company Information
11.17.2 EveryDose Digital Chronic Disease Management Product Offered
11.17.3 EveryDose Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 EveryDose Main Business Overview
11.17.5 EveryDose Latest Developments
11.18 Aptar Digital Health
11.18.1 Aptar Digital Health Company Information
11.18.2 Aptar Digital Health Digital Chronic Disease Management Product Offered
11.18.3 Aptar Digital Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Aptar Digital Health Main Business Overview
11.18.5 Aptar Digital Health Latest Developments
11.19 VITech
11.19.1 VITech Company Information
11.19.2 VITech Digital Chronic Disease Management Product Offered
11.19.3 VITech Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 VITech Main Business Overview
11.19.5 VITech Latest Developments
11.20 ClouDr Group
11.20.1 ClouDr Group Company Information
11.20.2 ClouDr Group Digital Chronic Disease Management Product Offered
11.20.3 ClouDr Group Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 ClouDr Group Main Business Overview
11.20.5 ClouDr Group Latest Developments
11.21 JD Health
11.21.1 JD Health Company Information
11.21.2 JD Health Digital Chronic Disease Management Product Offered
11.21.3 JD Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 JD Health Main Business Overview
11.21.5 JD Health Latest Developments
11.22 Ali Health
11.22.1 Ali Health Company Information
11.22.2 Ali Health Digital Chronic Disease Management Product Offered
11.22.3 Ali Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Ali Health Main Business Overview
11.22.5 Ali Health Latest Developments
11.23 Ping An Good Doctor
11.23.1 Ping An Good Doctor Company Information
11.23.2 Ping An Good Doctor Digital Chronic Disease Management Product Offered
11.23.3 Ping An Good Doctor Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Ping An Good Doctor Main Business Overview
11.23.5 Ping An Good Doctor Latest Developments
11.24 We Doctor Group
11.24.1 We Doctor Group Company Information
11.24.2 We Doctor Group Digital Chronic Disease Management Product Offered
11.24.3 We Doctor Group Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 We Doctor Group Main Business Overview
11.24.5 We Doctor Group Latest Developments
11.25 Wei Mai
11.25.1 Wei Mai Company Information
11.25.2 Wei Mai Digital Chronic Disease Management Product Offered
11.25.3 Wei Mai Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Wei Mai Main Business Overview
11.25.5 Wei Mai Latest Developments
11.26 Medlinker
11.26.1 Medlinker Company Information
11.26.2 Medlinker Digital Chronic Disease Management Product Offered
11.26.3 Medlinker Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Medlinker Main Business Overview
11.26.5 Medlinker Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

According to our LPI (LP Information) latest study, the global Digital Chronic Disease Management market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Digital Chronic Disease Management is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Digital Chronic Disease Management market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Digital Chronic Disease Management are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Digital Chronic Disease Management. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Digital Chronic Disease Management market.
Digital chronic disease management refers to the medical behavior and process of using online software or intelligent hardware to conduct regular detection, continuous monitoring, evaluation and comprehensive intervention management of chronic non-communicable diseases and their risk factors. Disease risk prediction, early warning and comprehensive intervention, as well as comprehensive management of chronic disease populations, evaluation of chronic disease effects, etc.
Key Features:
The report on Digital Chronic Disease Management market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Digital Chronic Disease Management market. It may include historical data, market segmentation by Type (e.g., Charge, Free), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Digital Chronic Disease Management market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Digital Chronic Disease Management market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Digital Chronic Disease Management industry. This include advancements in Digital Chronic Disease Management technology, Digital Chronic Disease Management new entrants, Digital Chronic Disease Management new investment, and other innovations that are shaping the future of Digital Chronic Disease Management.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Digital Chronic Disease Management market. It includes factors influencing customer ' purchasing decisions, preferences for Digital Chronic Disease Management product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Digital Chronic Disease Management market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Digital Chronic Disease Management market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Digital Chronic Disease Management market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Digital Chronic Disease Management industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Digital Chronic Disease Management market.
Market Segmentation:
Digital Chronic Disease Management market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Charge
Free
Segmentation by application
Medical Institutions
Pharmacy
Chronic Disease Patients
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
S3 Connected Health
WellDoc
AstraZeneca
NTT DATA
Credo Health Services
Dawn Health
Bayer
Medtronic
Teladoc Health
ScienceSoft
TriZetto Healthcare (Cognizant)
Omada Health
Phable
Pack Health
Epic Systems
Pathmate
EveryDose
Aptar Digital Health
VITech
ClouDr Group
JD Health
Ali Health
Ping An Good Doctor
We Doctor Group
Wei Mai
Medlinker



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Digital Chronic Disease Management Market Size 2018-2029
2.1.2 Digital Chronic Disease Management Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Digital Chronic Disease Management Segment by Type
2.2.1 Charge
2.2.2 Free
2.3 Digital Chronic Disease Management Market Size by Type
2.3.1 Digital Chronic Disease Management Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Digital Chronic Disease Management Market Size Market Share by Type (2018-2023)
2.4 Digital Chronic Disease Management Segment by Application
2.4.1 Medical Institutions
2.4.2 Pharmacy
2.4.3 Chronic Disease Patients
2.5 Digital Chronic Disease Management Market Size by Application
2.5.1 Digital Chronic Disease Management Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Digital Chronic Disease Management Market Size Market Share by Application (2018-2023)
3 Digital Chronic Disease Management Market Size by Player
3.1 Digital Chronic Disease Management Market Size Market Share by Players
3.1.1 Global Digital Chronic Disease Management Revenue by Players (2018-2023)
3.1.2 Global Digital Chronic Disease Management Revenue Market Share by Players (2018-2023)
3.2 Global Digital Chronic Disease Management Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Digital Chronic Disease Management by Regions
4.1 Digital Chronic Disease Management Market Size by Regions (2018-2023)
4.2 Americas Digital Chronic Disease Management Market Size Growth (2018-2023)
4.3 APAC Digital Chronic Disease Management Market Size Growth (2018-2023)
4.4 Europe Digital Chronic Disease Management Market Size Growth (2018-2023)
4.5 Middle East & Africa Digital Chronic Disease Management Market Size Growth (2018-2023)
5 Americas
5.1 Americas Digital Chronic Disease Management Market Size by Country (2018-2023)
5.2 Americas Digital Chronic Disease Management Market Size by Type (2018-2023)
5.3 Americas Digital Chronic Disease Management Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Digital Chronic Disease Management Market Size by Region (2018-2023)
6.2 APAC Digital Chronic Disease Management Market Size by Type (2018-2023)
6.3 APAC Digital Chronic Disease Management Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Digital Chronic Disease Management by Country (2018-2023)
7.2 Europe Digital Chronic Disease Management Market Size by Type (2018-2023)
7.3 Europe Digital Chronic Disease Management Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Digital Chronic Disease Management by Region (2018-2023)
8.2 Middle East & Africa Digital Chronic Disease Management Market Size by Type (2018-2023)
8.3 Middle East & Africa Digital Chronic Disease Management Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Digital Chronic Disease Management Market Forecast
10.1 Global Digital Chronic Disease Management Forecast by Regions (2024-2029)
10.1.1 Global Digital Chronic Disease Management Forecast by Regions (2024-2029)
10.1.2 Americas Digital Chronic Disease Management Forecast
10.1.3 APAC Digital Chronic Disease Management Forecast
10.1.4 Europe Digital Chronic Disease Management Forecast
10.1.5 Middle East & Africa Digital Chronic Disease Management Forecast
10.2 Americas Digital Chronic Disease Management Forecast by Country (2024-2029)
10.2.1 United States Digital Chronic Disease Management Market Forecast
10.2.2 Canada Digital Chronic Disease Management Market Forecast
10.2.3 Mexico Digital Chronic Disease Management Market Forecast
10.2.4 Brazil Digital Chronic Disease Management Market Forecast
10.3 APAC Digital Chronic Disease Management Forecast by Region (2024-2029)
10.3.1 China Digital Chronic Disease Management Market Forecast
10.3.2 Japan Digital Chronic Disease Management Market Forecast
10.3.3 Korea Digital Chronic Disease Management Market Forecast
10.3.4 Southeast Asia Digital Chronic Disease Management Market Forecast
10.3.5 India Digital Chronic Disease Management Market Forecast
10.3.6 Australia Digital Chronic Disease Management Market Forecast
10.4 Europe Digital Chronic Disease Management Forecast by Country (2024-2029)
10.4.1 Germany Digital Chronic Disease Management Market Forecast
10.4.2 France Digital Chronic Disease Management Market Forecast
10.4.3 UK Digital Chronic Disease Management Market Forecast
10.4.4 Italy Digital Chronic Disease Management Market Forecast
10.4.5 Russia Digital Chronic Disease Management Market Forecast
10.5 Middle East & Africa Digital Chronic Disease Management Forecast by Region (2024-2029)
10.5.1 Egypt Digital Chronic Disease Management Market Forecast
10.5.2 South Africa Digital Chronic Disease Management Market Forecast
10.5.3 Israel Digital Chronic Disease Management Market Forecast
10.5.4 Turkey Digital Chronic Disease Management Market Forecast
10.5.5 GCC Countries Digital Chronic Disease Management Market Forecast
10.6 Global Digital Chronic Disease Management Forecast by Type (2024-2029)
10.7 Global Digital Chronic Disease Management Forecast by Application (2024-2029)

11 Key Players Analysis
11.1 S3 Connected Health
11.1.1 S3 Connected Health Company Information
11.1.2 S3 Connected Health Digital Chronic Disease Management Product Offered
11.1.3 S3 Connected Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 S3 Connected Health Main Business Overview
11.1.5 S3 Connected Health Latest Developments
11.2 WellDoc
11.2.1 WellDoc Company Information
11.2.2 WellDoc Digital Chronic Disease Management Product Offered
11.2.3 WellDoc Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 WellDoc Main Business Overview
11.2.5 WellDoc Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Digital Chronic Disease Management Product Offered
11.3.3 AstraZeneca Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 NTT DATA
11.4.1 NTT DATA Company Information
11.4.2 NTT DATA Digital Chronic Disease Management Product Offered
11.4.3 NTT DATA Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 NTT DATA Main Business Overview
11.4.5 NTT DATA Latest Developments
11.5 Credo Health Services
11.5.1 Credo Health Services Company Information
11.5.2 Credo Health Services Digital Chronic Disease Management Product Offered
11.5.3 Credo Health Services Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Credo Health Services Main Business Overview
11.5.5 Credo Health Services Latest Developments
11.6 Dawn Health
11.6.1 Dawn Health Company Information
11.6.2 Dawn Health Digital Chronic Disease Management Product Offered
11.6.3 Dawn Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Dawn Health Main Business Overview
11.6.5 Dawn Health Latest Developments
11.7 Bayer
11.7.1 Bayer Company Information
11.7.2 Bayer Digital Chronic Disease Management Product Offered
11.7.3 Bayer Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Bayer Main Business Overview
11.7.5 Bayer Latest Developments
11.8 Medtronic
11.8.1 Medtronic Company Information
11.8.2 Medtronic Digital Chronic Disease Management Product Offered
11.8.3 Medtronic Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Medtronic Main Business Overview
11.8.5 Medtronic Latest Developments
11.9 Teladoc Health
11.9.1 Teladoc Health Company Information
11.9.2 Teladoc Health Digital Chronic Disease Management Product Offered
11.9.3 Teladoc Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Teladoc Health Main Business Overview
11.9.5 Teladoc Health Latest Developments
11.10 ScienceSoft
11.10.1 ScienceSoft Company Information
11.10.2 ScienceSoft Digital Chronic Disease Management Product Offered
11.10.3 ScienceSoft Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 ScienceSoft Main Business Overview
11.10.5 ScienceSoft Latest Developments
11.11 TriZetto Healthcare (Cognizant)
11.11.1 TriZetto Healthcare (Cognizant) Company Information
11.11.2 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Product Offered
11.11.3 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 TriZetto Healthcare (Cognizant) Main Business Overview
11.11.5 TriZetto Healthcare (Cognizant) Latest Developments
11.12 Omada Health
11.12.1 Omada Health Company Information
11.12.2 Omada Health Digital Chronic Disease Management Product Offered
11.12.3 Omada Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Omada Health Main Business Overview
11.12.5 Omada Health Latest Developments
11.13 Phable
11.13.1 Phable Company Information
11.13.2 Phable Digital Chronic Disease Management Product Offered
11.13.3 Phable Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Phable Main Business Overview
11.13.5 Phable Latest Developments
11.14 Pack Health
11.14.1 Pack Health Company Information
11.14.2 Pack Health Digital Chronic Disease Management Product Offered
11.14.3 Pack Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Pack Health Main Business Overview
11.14.5 Pack Health Latest Developments
11.15 Epic Systems
11.15.1 Epic Systems Company Information
11.15.2 Epic Systems Digital Chronic Disease Management Product Offered
11.15.3 Epic Systems Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Epic Systems Main Business Overview
11.15.5 Epic Systems Latest Developments
11.16 Pathmate
11.16.1 Pathmate Company Information
11.16.2 Pathmate Digital Chronic Disease Management Product Offered
11.16.3 Pathmate Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Pathmate Main Business Overview
11.16.5 Pathmate Latest Developments
11.17 EveryDose
11.17.1 EveryDose Company Information
11.17.2 EveryDose Digital Chronic Disease Management Product Offered
11.17.3 EveryDose Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 EveryDose Main Business Overview
11.17.5 EveryDose Latest Developments
11.18 Aptar Digital Health
11.18.1 Aptar Digital Health Company Information
11.18.2 Aptar Digital Health Digital Chronic Disease Management Product Offered
11.18.3 Aptar Digital Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Aptar Digital Health Main Business Overview
11.18.5 Aptar Digital Health Latest Developments
11.19 VITech
11.19.1 VITech Company Information
11.19.2 VITech Digital Chronic Disease Management Product Offered
11.19.3 VITech Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 VITech Main Business Overview
11.19.5 VITech Latest Developments
11.20 ClouDr Group
11.20.1 ClouDr Group Company Information
11.20.2 ClouDr Group Digital Chronic Disease Management Product Offered
11.20.3 ClouDr Group Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 ClouDr Group Main Business Overview
11.20.5 ClouDr Group Latest Developments
11.21 JD Health
11.21.1 JD Health Company Information
11.21.2 JD Health Digital Chronic Disease Management Product Offered
11.21.3 JD Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 JD Health Main Business Overview
11.21.5 JD Health Latest Developments
11.22 Ali Health
11.22.1 Ali Health Company Information
11.22.2 Ali Health Digital Chronic Disease Management Product Offered
11.22.3 Ali Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Ali Health Main Business Overview
11.22.5 Ali Health Latest Developments
11.23 Ping An Good Doctor
11.23.1 Ping An Good Doctor Company Information
11.23.2 Ping An Good Doctor Digital Chronic Disease Management Product Offered
11.23.3 Ping An Good Doctor Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Ping An Good Doctor Main Business Overview
11.23.5 Ping An Good Doctor Latest Developments
11.24 We Doctor Group
11.24.1 We Doctor Group Company Information
11.24.2 We Doctor Group Digital Chronic Disease Management Product Offered
11.24.3 We Doctor Group Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 We Doctor Group Main Business Overview
11.24.5 We Doctor Group Latest Developments
11.25 Wei Mai
11.25.1 Wei Mai Company Information
11.25.2 Wei Mai Digital Chronic Disease Management Product Offered
11.25.3 Wei Mai Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Wei Mai Main Business Overview
11.25.5 Wei Mai Latest Developments
11.26 Medlinker
11.26.1 Medlinker Company Information
11.26.2 Medlinker Digital Chronic Disease Management Product Offered
11.26.3 Medlinker Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Medlinker Main Business Overview
11.26.5 Medlinker Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/06/18 10:26

158.74 円

170.83 円

204.52 円

ページTOPに戻る